Evaluation of the costs of Transient Elastography (FibroScan ®) in the diagnosis of liver fibrosis in HIV patients with hepatitis C virus;Evaluación económica de la elastografía de transición (FibroScan®) en el diagnóstico de fibrosis hepática en pacientes con hepatitis C coinfectados con VIH

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 30, Issue 6, 2012, Pages 294-299

  García Jurado, Laura ^a   Oyagüez, Itziar ^a   Casado, Miguel Ángel ^a   Tural, Cristina ^b   González García, Juan ^c   Ortega, Enrique ^d   Pineda, Juan Antonio ^e  

^a Pharmacoeconomics and Outcomes Research Iberia (PORIB)   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^e HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

Economic Evaluation; HIV HCV Coinfection; Liver Biopsy; Transient Elastography

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; ECONOMIC EVALUATION; ELASTOGRAPHY; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH STATUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EXPECTANCY; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MIXED INFECTION; PATIENT MONITORING; PROGNOSIS; SENSITIVITY ANALYSIS; SIMULATION; TRANSIENT ELASTOGRAPHY;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; BIOPSY; CHILD; CHILD, PRESCHOOL; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DISEASE PROGRESSION; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEALTH EXPENDITURES; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MARKOV CHAINS; MIDDLE AGED; MODELS, BIOLOGICAL; MODELS, ECONOMIC; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; YOUNG ADULT;

EID: 84862840797     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2011.11.004     Document Type: Article

References (41)

1. G. Bejarano, M. Vergara, M. Gil, B. Dalmau, J. Puig, and M.R. Bella Prospective evaluation of liver fibrosis in chronic viral hepatitis C infection using the Sabadell NIHCED (non-invasive hepatitis C related cirrhosis early detection) index Rev Esp Enferm Dig 101 2009 325 335
2. Labarga P, Vispo ME, Barreiro P, Tuma P, Pinilla J, Martín- Carbonero L. ¿Es necesaria la biopsia hepática en coinfectados por VIH y VHC? AIDS Cyber J [revista electronica] 2008;11(5) [consultado 6 May 2011]. Disponible en: http://www.ttmed.com/sida/
3. S.A.E.I. Grupo para el Estudio de las Hepatitis Viricas de la The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection Clin Infect Dis 45 2007 969 974
4. L. Martín-Carbonero, Y. Benhamou, M. Puoti, J. Berenguer, J. Mallolas, and C. Quereda Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic Hepatitis C: A European Collaborative Study Clin Infect Dis 38 2004 128 133 (Pubitemid 38045883)
5. M. Sánchez-Conde, J. Berenguer, P. Miralles, F. Alvarez, J. Carlos Lopez, and J. Cosin Liver Biopsy Findings for HIV-Infected Patients with Chronic Hepatitis C and Persistently Normal Levels of Alanine Aminotransferase Clin Infect Dis 43 2006 640 644 (Pubitemid 44267128)
6. A.A. Bravo, S.G. Sheth, and S. Chopra Liver biopsy N Engl J Med 344 2001 495 500 (Pubitemid 32164902)
7. American Association for the Study of Liver Diseases Diagnosis, Management, and Treatment of Hepatitis C Hepatology 39 2004 1147 1171
8. P. Bedossa, D. Darge're, and V. Paradis Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38 2003 1449 1457 (Pubitemid 37466971)
9. M. Friedrich-Rust, W. Rosenberg, J. Parkes, E. Herrmann, S. Zeuzem, and C. Sarrazin Comparison of ELF, FibroTest and FibroScan® for the non-invasive assessment of liver fibrosis BMC Gastroenterology 10 2010 103
10. M.C. Rousselet, S. Michalak, F. Dupre, A. Croue, P. Bedossa, and J.P. Saint-Andre Sources of variability in histological scoring of chronic viral hepatitis Hepatology 41 2005 257 264 (Pubitemid 40165369)
11. ®), a new non-invasive method to evaluate hepatic fibrosis Med Clin (Barc) 126 2006 220 222
12. L. Sandrin, B. Fourquet, J.M. Hasquenoph, S. Yon, C. Fournier, and F. Mal Transient elastography: a new non-invasive method for assessment of hepatic fibrosis Ultrasound Med Biol 29 2003 1705 1713 (Pubitemid 38091720)
13. J.A. Carrión, J. Colmenarejo, R. Bataller, and X. Forns Diagnóstico no invasivo de la fibrosis hepática Gastroenterol Hepatol 30 Supl 1 2007 106 112
14. L. Castera, X. Forns, and A. Alberti Non-invasive evaluation of liver fibrosis using transient elastography J Hepatol 48 2008 835 847
15. M. Moreno, R. Pérez-Alvarez, L. Rodrigo, R. Pérez- López, and M. González Long-term evolution of liver histopathology in patients with chronic hepatitis C and sustained response Rev Esp Enferm Dig 97 2005 860 869 (Pubitemid 44483731)
16. P. Bedossa, and T. Poynard An algorithm for the grading of activity in chronic hepatitis C Hepatology 24 1996 289 293 (Pubitemid 26260021)
17. C. Tural, E. Ortega, J.A. Pineda, J. Gonzalez-García, L. Griffa, and E. Cabrero Cross-sectional study to determine prevalence of significant liver fibrosis (F2-F4) in HIV/HCV co-infected patients: GRAFIHCO study J Int AIDS Soc 1 Suppl 1 2008 P264
18. Griffa L, Del Valle J, Macías J, Burgos A, Pineda JA, Tural C, et al. Prevalencia y factores asociados a fibrosis hepática significativa (FHS) medida por métodos no invasivos en pacientes co-infectados VIH/VHC. I Congreso Nacional de GESIDA. Madrid, 2009. #OR-10.
19. J. Macías, J. González, E. Ortega, C. Tural, L. Griffa, A. Burgos on behalf of the GRAFIHCO Study Team Use of simple non-invasive biomarkers to predict liver fibrosis in HIV/HCV co-infection in daily clinical practice 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention Cape Town 2009
20. Grupo para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients Clin Infect Dis 49 2009 1274 1282
21. V. Soriano, A. Mocroft, J. Rockstroh, B. Ledergerber, B. Knysz, and S. Chaplinskas EuroSIDA Study Group. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe J Infect Dis 198 2008 1337 1344
22. S. Deuffic, L. Buffat, T. Poynard, and A.J. Valleron Modeling the Hepatitis C Virus Epidemic in France Hepatology 29 1999 1596 1601 (Pubitemid 29211066)
23. M. Laguno, C. Cifuentes, J. Murillas, S. Veloso, M. Larrousse, and A. Payeras Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients Hepatology 49 2009 22 31
24. A. Briggs, and M. Sculpher An introduction to Markov modelling for economic evaluation Pharmacoeconomics 13 1998 397 409 (Pubitemid 28140699)
25. U. Siebert, G. Sroczynski, S. Rossol, J. Wasem, U. Ravens-Sieberer, and B.M. Kurth Cost effectiveness of peginterferon a-2b plus ribavirin versus interferon a-2b plus ribavirin for initial treatment of chronic hepatits C Gut 52 2003 425 432 (Pubitemid 36250066)
26. J. López Bastida, J. Oliva, F. Antoñanzas, A. García-Altés, R. Gisbert, and J. Mar A proposed guideline for economic evaluation of health technologies Gac Sanit 24 2010 154 170
27. M. Buti, M.A. Casado, L. Fosbrook, and R. Esteban Coste-efectividad del tratamiento de la hepatitis crónica C con interferon alfa Gastroenterol Hepatol 21 1998 161 168 (Pubitemid 28280040)
28. M. Buti, M.A. Casado, L. Fosbrook, J.B. Wong, and R. Esteban Cost-effectiveness of combination therapy for naive patients with chronic hepatitis C J Hepatol 33 2000 651 658
29. M. Buti, M. Medina, M.A. Casado, J.B. Wong, L. Fosbrook, and R. Esteban A cost-effectiveness analysis of peginterferon alfa-2b plus ribavirin for the treatment of naive patients with chronic hepatitis C Aliment Pharmacol Ther 17 2003 687 694 (Pubitemid 36418893)
30. M. Buti, M.A. Casado, J.L. Calleja, J. Salmerón, J. Aguilar, and M. Rueda A Cost-effectiveness analysis of two oral antiviral drugs for treatment of HBeAg-negative chronic hepatitis B patients Aliment Pharmacol Ther 23 2006 409 419 (Pubitemid 43382021)
31. M. Buti, M. Brosa, M.A. Casado, M. Rueda, and R. Esteban Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B J Hepatol 51 2009 640 646
32. O. Haj-Ali Saflo, and J.M. Hernández Guijo Coste-eficacia del tratamiento de la hepatitis C crónica en España Gastroenterol Hepatol 32 2009 472 482
33. Oblikue Consulting Base de datos sanitarios e-Salud [consultado Jul 2011]. Disponible en: http://www. oblikue.com/bddcostes/
34. ®) en el diagnóstico de fibrosis hepática: revisión sistemática y meta-análisis. Julio 2009 [consultado Jul 2011]. Disponible en: http://www.isciii.es/htdocs/investigacion/ publi-agencia
35. INE. Instituto Nacional de Estadística. Sociedad. Nivel, calidad y condiciones de vida. Indice de Precios de Consumo [consultado Jul 2011]. Disponible en: http://www.ine.es
36. J. Branera, J. Puig, M. Gil, R. Bella, A. Darnell, and A. Malet Punción biopsia hepática ambulatoria guiada por ultrasonografía: descripción técnica y complicaciones Radiologia 47 2005 32 36 (Pubitemid 40343409)
37. J.J. González-García, B. Mahillo, S. Hernández, R. Pacheco, S. Diz, and P. García Estudio multicéntrico sobre prevalencia de las coinfecciones por virus de hepatitis, indicación de tratamiento de hepatitis crónica C y necesidad de trasplante hepático en pacientes infectados por el VIH en España. Estudio GESIDA 29/02-FIPSE 12185/01 Enferm Infecc Microbiol Clin 23 2005 340 348 (Pubitemid 41020545)
38. L. Castéra, J. Vergniol, J. Foucher, B. Le Bail, E. Chanteloup, and M. Haaser Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C Gastroenterology 128 2005 343 350 (Pubitemid 40439195)
39. M. Ziol, A. Handra-Luca, A. Kettaneh, C. Christidis, F. Mal, and F. Kazemi Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C Hepatology 41 2005 48 54 (Pubitemid 40066382)
40. V. De Lédinghen, C. Douvin, A. Kettaneh, M. Ziol, D. Roulot, and P. Marcellin Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients J Acquir Immune Defic Syndr 41 2006 175 179
41. S. Vergara, J. Macías, A. Rivero, A. Gutiérrez-Valencia, M. González-Serrano, D. Merino Grupo para el Estudio de las Hepatitis Viricas de la SAEI The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection Clin Infect Dis 45 2007 969 974 (Pubitemid 47580344)